Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solutionPRNewsWire • 06/08/26
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026Zacks Investment Research • 06/02/26
Integrated DNA Technologies Announces End-to-End Oncology Research Workflows Optimized on Illumina Software for Faster InsightsBusiness Wire • 06/01/26
Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology researchPRNewsWire • 05/28/26
Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD researchPRNewsWire • 05/28/26
Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impactPRNewsWire • 05/19/26
What CEOs from Tesla, Nvidia and over a dozen other companies hope to gain by joining Trump in ChinaMarket Watch • 05/13/26
ILMN Stock Up on Q1 Earnings & Revenue Beat, Margins Expand, '26 View UpZacks Investment Research • 05/01/26
Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 05/01/26
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?Zacks Investment Research • 04/30/26
Unlocking Q1 Potential of Illumina (ILMN): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 04/29/26
DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflowsPRNewsWire • 04/16/26